Chargement en cours...
Voclosporin: First Approval
Voclosporin (Lupkynis(™)) is an oral calcineurin inhibitor immunosuppressant that is being developed by Aurinia Pharmaceuticals. In January 2021, based on positive results from the pivotal phases II and III trials, oral voclosporin received its first approval in the USA for use in combination with a...
Enregistré dans:
| Publié dans: | Drugs |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer International Publishing
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8010786/ https://ncbi.nlm.nih.gov/pubmed/33788181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01488-z |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|